Sunday, October 11, 2026

Tech Stocks

9 articles

Nebius Stock Surges 229.9% in H1 2026 After Nvidia's $2B Investment

Nebius Stock Surges 229.9% in H1 2026 After Nvidia's $2B Investment

Nvidia poured $2 billion each into Nebius and CoreWeave, and Nebius shares responded with a 229.9% rally in H1 2026. The move signals Nvidia is using direct equity stakes to lock in GPU cloud capacity and steer AI infrastructure buildout toward partners it controls financially.

LM Salvado•
Goldman Sachs Flags 7pp ROE Drop for Big Tech as AI Capex Fails to Deliver Returns

Goldman Sachs Flags 7pp ROE Drop for Big Tech as AI Capex Fails to Deliver Returns

Goldman Sachs has forecast a 7-percentage-point decline in return on equity for Big Tech, citing AI capital expenditure that has not yet translated into profits. The report signals growing institutional concern over AI spending cycles and margin compression. Analysts warn of near-term derating risk for AI infrastructure stocks.

LM Salvado•
NVIDIA Unveils 10+ Products at GTC Taipei, Targeting Dell, HPE, Super Micro Revenue Surge in H2 2026

NVIDIA Unveils 10+ Products at GTC Taipei, Targeting Dell, HPE, Super Micro Revenue Surge in H2 2026

NVIDIA launched over 10 products and partnerships at GTC Taipei, spanning the Vera CPU, RTX Spark PCs, DGX Station, Cosmos 3, and an Agent Toolkit. The announcements span CPU, edge AI, data center, robotics, and autonomous vehicles — all built on existing ODM supply chains. Dell, HPE, Lenovo, and Super Micro are positioned as primary revenue beneficiaries heading into late 2026.

LM Salvado•
Nvidia Jumps ~20% Post-Earnings as Vera Rubin Launch Signals AI GPU Demand Is Structural

Nvidia Jumps ~20% Post-Earnings as Vera Rubin Launch Signals AI GPU Demand Is Structural

Nvidia posted a roughly 20% surge following its latest earnings report, with the Vera Rubin architecture launch confirming hyperscaler AI compute spending remains elevated. The semiconductor sector is bifurcating: Nvidia dominates data center GPU supply, while a second tier of edge inference, optical interconnect, and power semiconductor players repositions for the next phase. A 2027 U.S. ban on Chinese-origin rare earth materials in defense systems is accelerating supply chain reshoring across

LM Salvado•
US Takes Equity Stakes in Semiconductor Firms as AI Chip Supply Becomes National Priority

US Takes Equity Stakes in Semiconductor Firms as AI Chip Supply Becomes National Priority

The US government is moving beyond subsidies to direct equity ownership in semiconductor infrastructure, marking a fundamental shift in AI hardware supply policy. This strategic intervention aims to secure domestic chip production capacity for AI companies through government-backed financing. The change suggests semiconductor allocation will increasingly follow strategic priorities rather than pure market dynamics.

LM Salvado•
Semiconductor Equipment Makers Eye Growth as U.S. Pushes Domestic Chip Production

Semiconductor Equipment Makers Eye Growth as U.S. Pushes Domestic Chip Production

The U.S. ban on Chinese rare earth materials in defense systems starting 2027 is driving semiconductor supply chain restructuring, creating opportunities for equipment and materials suppliers. Camtek secured a $31M AI packaging order while companies like Aehr Test Systems, Entegris, and SEALSQ adapt to new domestic production requirements. Intel's Terafab initiative and expanded domestic capacity signal increased demand for specialized manufacturing equipment.

LM Salvado•
NVIDIA Expands AI Drug Discovery Platform Through Pharmaceutical Partnerships

NVIDIA Expands AI Drug Discovery Platform Through Pharmaceutical Partnerships

NVIDIA is positioning its BioNeMo platform as foundational infrastructure for AI-enabled drug discovery through partnerships with pharmaceutical companies including Eli Lilly and Thermo Fisher. The chipmaker is establishing itself as critical middleware between AI compute and biotech applications, enabling a new ecosystem of AI-driven lab workflows.

LM Salvado•
Capital Rotation Accelerates as AI Chip Plays Diverge From Consumer Semiconductor Laggards

Capital Rotation Accelerates as AI Chip Plays Diverge From Consumer Semiconductor Laggards

The semiconductor sector is splitting into clear winners and losers as institutional capital flows toward AI infrastructure enablers like Broadcom and Marvell, while chip suppliers tied to consumer electronics and automotive markets face persistent headwinds. Marvell's forecast of 40%-plus full-year revenue growth—anchored by its Celestial AI custom silicon roadmap—underscores the scale of the opportunity drawing investors away from legacy chip verticals. Macro uncertainty around labor markets a

ViaNews Editorial Team (Markets)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com